China Universal Asset Management »

Springworks Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $663k 15k 44.13
2024-12-31 $570k 16k 36.13
2024-09-30 $458k 14k 32.04
2024-06-30 $328k 8.7k 37.67
2024-03-31 $699k 14k 49.25
2023-12-31 $264k 7.2k 36.48
2023-09-30 $37k 1.6k 22.95
2023-06-30 $22k 820 26.83
2023-03-31 $22k 847 25.97
2022-12-31 $16k 634 25.24
2022-09-30 $13k 463 28.08

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding Springworks Therapeutics

Morgan Stanley
DekaBank Deutsche Girozentrale
E Fund Management
Advisor Group Holdings
FTB Advisors
Huntington National Bank

View all funds holding Springworks Therapeutics